ARCHIVES

Organ Systems Program Progress, Momentum Threatened During transition, Karr Contends

This article is from The Cancer Letter archive.

Vol. 14 No. 48 | December 9, 1988

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI Listed For September

September 24, 2004

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

June 26, 2013

Longterm Followup Finds Taxotere Improves Survival

January 25, 2008

Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President.

March 23, 2007

Advisors Approve Program To Link Radiation Oncologists.

June 29, 2001